Skip to content

To check Digestive Fire in Intestinal disorder before and after Ayurvedic management

Assessment of Agnibala in Vataj Grahani before and after Ayurvedic intervention - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057572
Enrollment
45
Registered
2023-09-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

None listed

Sponsors

Department of Kriya Sharir Faculty of Ayurveda Institute of Medical SciencesVaranasi Uttar Pradesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willing to participate in the study. 2.Patients of either sex with age between 18-60 years. 3.Patients with history of Vataj Grahani less than 5 years. 4.Patients presenting with classical features of Vataj Grahani.

Exclusion criteria

Exclusion criteria: 1.Patients of either sex below 18 year and above 60 years will be excluded from the study. 2.Patients with features of bleeding per rectum, mixed infection and evidence of malignancy. 3.Patients with diabetes mellitus, poorly controlled hypertension,major cardiac problems. 4.Patients on prolonged ( >6 weeks) medication with corticosteroids,anti-depressants, anti-cholinergics, etc., or any other drugs that may have an influence on the outcome of the study. 5.Patients suffering from major systemic illness necessitating long term drug treatment Rheumatoid arthritis, tuberculosis, psycho-neuro-endocrinal disorders, etc. 6.Patients with concurrent serious hepatic disorder or renal disorders,severe pulmonary dysfunction or any other condition that may jeopardize the study. 7.Alcoholics and/or drug abusers.History of hypersensitivity to the trial drug or any of its ingredients. 8.Pregnant/lactating woman. 9.Patients who have completed participation in any other clinical trial during the past 6 months. 10.Any other conditions, which the principal investigator thought excluded the patient.

Design outcomes

Primary

MeasureTime frame
Assessment of Agnibala (validated Questionnaire)Timepoint: 3-month study with follow-up 15 days

Secondary

MeasureTime frame
NATimepoint: NA

Countries

India

Contacts

Public ContactDr Saurabh Rahi

Institute of Medical Sciences, Banaras Hindu University

saurabh.rahi91@gmail.com9044446801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026